Latest Breaking News On - Janssen bayer - Page 2 : comparemela.com

DOACs reduce risk for dementia in AF vs warfarin, especially in Asian patients

DOACs reduce risk for dementia in AF vs warfarin, especially in Asian patients
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Singapore generalJanssen bayerBristol myers squibbDaiichi sankyoBoehringer ingelheimHsen tanChangi general hospitalBristol myers

In frail patients with AF, switching to newer anticoagulants raises bleeding risk

In frail patients with AF, switching to newer anticoagulants raises bleeding risk
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Geert jan geersingDaiichi sankyoJanssen bayerBristol myers squibbBoehringer ingelheimUtrecht universityJulius centerEuropean society of cardiology congressEuropean societyJan geersingBristol myers

New virtual learning hub underscores importance of patient-centered care in PAD and CAD

New virtual learning hub underscores importance of patient-centered care in PAD and CAD
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoJanssen bayerIsabel bjorkClara gomez sanchezUniversity of californiaFoundation to advance vascular curesAdvance vascular curesLearning hubVascular cures

CytoSorbents Completes Enrollment of the STAR-T Pivotal Trial

PRINCETON, N.J., July 07, 2023 CytoSorbents Corporation , a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using blood purification via its.

United statesTicagrelor brilintaJanssen bayerKathleen blochRichard whitlockEfthymiosn deliargyrisMichael mackC michael gibsonEuropean unionUs department of healthBlood instituteNational heartUs armyCytosorbents corporationUs airHealth canada

CytoSorbents Completes Enrollment of the STAR-T Pivotal Trial - CytoSorbents (NASDAQ:CTSO)

PRINCETON, N.J., July 07, 2023 (GLOBE NEWSWIRE) CytoSorbents Corporation (NASDAQ:CTSO), a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using blood purification via its

United statesRichard whitlockJanssen bayerC michael gibsonEfthymiosn deliargyrisKathleen blochMichael mackCytosorbents corporationTicagrelor brilintaMaterial commandUs department of healthEuropean unionUs airBlood instituteNational institutes of healthNational heart